Auswahl der wissenschaftlichen Literatur zum Thema „Incompatibilités physico-chimiques“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Incompatibilités physico-chimiques" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Incompatibilités physico-chimiques"
Chaabna, Manel, Lina Aissa, Fadhila Debbah und Nassima Taleb. „Physico-chemical incompatibilities“. Batna Journal of Medical Sciences (BJMS) 1, Nr. 2 (31.12.2014): 107–10. http://dx.doi.org/10.48087/bjmstf.2014.1212.
Der volle Inhalt der QuelleTardy, C., O. Maison, A. Faudel, L. Sarfati, G. Iroir, C. Rioufol, A. Lepape und S. Parat. „Incompatibilités médicamenteuses physico-chimiques en unités de soins intensifs : état des lieux et mise en place de mesures préventives“. Le Pharmacien Hospitalier et Clinicien 52, Nr. 1 (März 2017): e18. http://dx.doi.org/10.1016/j.phclin.2017.01.047.
Der volle Inhalt der QuelleChapuis, Claire, Émeline Daru, Claire Trochet, Prudence Gibert und Pierrick Bedouch. „Les incompatibilités physico-chimiques“. La Revue de l'Infirmière, Oktober 2023. http://dx.doi.org/10.1016/j.revinf.2023.09.015.
Der volle Inhalt der QuelleBruno, Bénédicte, Lucie Capelle, Virginie Denis, Olivier Duval, Sorea Selmouni, Alban Villate, Delphine Cabelguenne et al. „Interactions médicamenteuses et incompatibilités physico-chimiques en phase aiguë post-allogreffe : quelle influence des médicaments de support ? Recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)“. Bulletin du Cancer, Mai 2022. http://dx.doi.org/10.1016/j.bulcan.2022.02.004.
Der volle Inhalt der QuelleDissertationen zum Thema "Incompatibilités physico-chimiques"
Roche, Marine. „Développement de méthodes analytiques pour l'étude de la stabilité et de la compatibilité de médicaments sous forme de solution ou de systèmes dispersés. Application en anesthésie-réanimation“. Electronic Thesis or Diss., Université de Lille (2022-....), 2024. http://www.theses.fr/2024ULILS021.
Der volle Inhalt der QuelleThe research subject of this PhD focused on the development of analytical methods to assess the stability or incompatibilities of injectable anaesthetic drugs in solution or in dispersed systems.The first part of this work involved a study of the stability of cisatracurium besylate ampoules produced by the pharmacy of Lille University Hospital to ensure continuity of care for intensive care patients in the context of supply disruptions caused by the COVID-19 pandemic. The stability study was conducted on a batch of 4,000 ampoules stored at 2-8°C for 18 months. This study required the validation of a stability-indicating HPLC-UV method for the determination of cisatracurium and laudanosine, one of its degradation products described as a marker of its instability. In addition, the use of an HPLC-mass spectrometry method enabled the identification of degradation products and the study of degradation pathways. Our results showed that cisatracurium solutions at 10mg/mL were stable for 15 months under our preparation and storage conditions. The main degradation pathway observed under our study conditions (ester hydrolysis) differed from that previously described (Hofmann pathway). This highlights the imponderability of conducting stability studies under conditions representative of the actual use of drugs. The second part of this thesis led us to study the incompatibility between different drugs used in anaesthesia and intensive care units. The models studied were the simultaneous administration of propofol and alpha-2 adrenergic receptor agonists (α2A; clonidine or dexmedetomidine) used in multimodal analgesia. The data available in the literature refers to concentrations and ratios that are not representative of those encountered in hospital wards, potentially exposing patients to drug hazards. We assessed the compatibility of propofol-α2A combinations under conditions mimicking those encountered in critical care units. Eight conditions per combination were evaluated over 96 hours, in triplicate, varying the simulated mass flow rates for each drug and for patient weights of 45 and 150 kg. To assess the chemical compatibility of these combinations, we developed and validated 3 stability-indicating HPLC-UV assay methods to study the stability of propofol, clonidine and dexmedetomidine in combination for 96 hours. The physical compatibility of the emulsion in combination was assessed using a granulometer coupled to a zeta potential measurement (with positive and negative controls). Our results demonstrated the physico-chemical stability of propofol-α2A mixtures representative of those used in current practice.In conclusion, the results of this work have provided scientific validation of hospital pharmacy and care service practices. They also highlighted the fundamental role of pharmacists in guaranteeing the quality of patient drug management, by using their skills in analytical chemistry to assess compatibility and stability data